C.
Live / Registered — Registered (as of 11 Mar 2025)
What this means for you
Registered since 11 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97979331
- Registration number
- 7725052
- Mark type
- Design + words
- Filed
- 07 Mar 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 11 Mar 2025
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
- Class 042 — Scientific and technological services: research in the field of cellular assay screening and pharmaceutical discovery and development
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 11 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Feb 2025 — ASSIGNED TO LIE
- 12 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Nov 2024 — NON-FINAL ACTION E-MAILED
- 23 Nov 2024 — SU - NON-FINAL ACTION - WRITTEN
- 22 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Aug 2024 — USE AMENDMENT FILED
- 22 Nov 2024 — DIVISIONAL PROCESSING COMPLETE
- 20 Aug 2024 — DIVISIONAL REQUEST RECEIVED